Tag: ischaemic stroke
Growing haemorrhagic stroke burden in USA represents “major challenge” moving forward
The past three decades have seen a “notable rise” in the burden of haemorrhagic stroke across the USA and this, coupled with the increasing...
US study finds link between social factors and intravenous thrombolysis rate
For ischaemic stroke patients, social factors like education, neighbourhood and employment may be linked to whether they receive treatment with intravenous, clot-busting drugs, according...
One-year TESLA and SELECT2 data favour thrombectomy in large-core stroke patients
One-year follow-up data from two randomised controlled trials (RCTs) evaluating mechanical thrombectomy in patients with ischaemic strokes caused by large-core infarct volumes have demonstrated...
Halted MOST trial finds no benefit when adding blood thinners to...
Giving blood thinners in addition to clot-busting medications does not improve ischaemic stroke patients’ outcomes at 90 days, according to findings from the MOST trial, which...
Ischaemic stroke—we are all vulnerable
Conrad Yiu, a pioneer and visionary in interventional ischaemic stroke therapy, passed away in the final weeks of 2023, succumbing to the very disease for...
Tigertriever device produces high treatment-success rate in challenging ICAD stroke patients
Rapid Medical has announced new data demonstrating “excellent” first-pass treatment success using the Tigertriever device in complex ischaemic stroke patients with underlying intracranial atherosclerotic disease (ICAD)....
Patients in lower socioeconomic status areas less likely to receive acute...
People who live in neighbourhoods with lower socioeconomic status are less likely to receive clot-busting medications or undergo mechanical thrombectomy procedures after they have...
Upcoming technologies set to forebear “new era” in prehospital stroke care
While the latest thrombectomy techniques, thrombolytic drug candidates and even neuroprotective agents are the source of much discussion in today’s neurovascular space, there is...
New data suggest faster and less costly thrombectomy procedures with Zoom...
Imperative Care recently announced the publication of clinical data in the journal Interventional Neuroradiology (INR) detailing the use of its Zoom aspiration catheters in...
New eligibility criteria including large-core strokes could boost thrombectomy rates “dramatically”
A study presented on the first day of the 2023 Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has...
Microvention announces commercial availability of ERIC retrieval device in the USA
Microvention, a wholly owned subsidiary of Terumo, has announced that the ERIC retrieval device is now commercially available in the USA for ischaemic stroke treatment, having...
Researchers identify novel protein linked to ischaemic stroke risk in older...
By identifying plasma proteomic determinants of incident cardioembolic and non-cardioembolic ischaemic stroke, researchers in the USA have found a novel protein believed to be...
Imperative announces data demonstrating benefits of Zoom RDL system in neurointerventional...
Imperative Care has announced the publication of early clinical data in the Journal of NeuroInterventional Surgery (JNIS) from a single-centre evaluation of the Zoom RDL radial...
MAGNA meta-analysis further supports clinical benefit of EVT in large-core infarct...
The MAGNA meta-analysis of individual patient data (IPD) has provided “strong, generalisable evidence” on the clinically meaningful benefits of endovascular therapy (EVT) in ischaemic...
TESLA trial misses primary endpoint but exhibits “strong suggestion” favouring endovascular...
The results of the TESLA trial were recently presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), demonstrating a “strong suggestion”...
IRIS data shed new light on how treatment delays may impact...
A collaboration analysing several major clinical trials has found that endovascular therapy (EVT) plus intravenous thrombolysis (IVT) is likely to be superior to EVT...
Performance feedback significantly reduces door-to-groin time in endovascular therapy
Supplying healthcare providers with performance feedback can significantly reduce the time between an ischaemic stroke patient arriving at a hospital and them subsequently receiving...
Early anticoagulation after ischaemic stroke “reasonable” and “unlikely to cause harm”
An international clinical trial presented today at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has demonstrated that—in people with ischaemic stroke...
Paediatric case helps highlight benefit of ‘aspiration first’ in young stroke...
A unique case presentation at this year’s LINNC Americas Seminar (16–17 March, Miami, USA) saw Rafael de Oliveira Sillero (University of Texas Southwestern Medical...
Athersys announces changes to MASTERS-2 trial endpoints following US FDA meeting
Athersys has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B meeting with the US Food and Drug Administration (FDA)....
The positive clinical impact of a comprehensive, compatible stroke solutions portfolio
This advertorial is sponsored by CERENOVUS.
Following the recent addition of the EMBOGUARD balloon guide catheter (BGC) to the CERENOVUS STROKE SOLUTIONSi portfolio of devices,...
Athersys granted clinical Type B meeting with US FDA to discuss...
Athersys, the company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced recently that it has been granted a clinical Type B meeting with...
Celery seed derivative shows promise as neuroprotectant in acute ischaemic stroke
Ischaemic stroke patients treated with a clot-busting medication and/or mechanical thrombectomy who also received butylphthalide—a novel medication initially compounded from celery seed—experienced milder neurological...
Two cardiovascular medicines found to be “well-tolerated” in small vessel stroke
A study of two widely used cardiovascular medications—cilostazol and isosorbide mononitrate—in more than 350 patients has confirmed that both were well-tolerated and safe for...
Continuous monitoring detects atrial fibrillation in 20% of atherosclerotic stroke survivors
In a study presented yesterday at the International Stroke Conference (ISC; 8–10 February, Dallas, USA), irregular heart rhythms were detected in roughly one in...
Basking Biosciences to present trial data on novel reversible thrombolytic agent...
Basking Biosciences has announced that it will be presenting three oral presentations and two moderated posters concerning the company’s novel drug candidate—a reversible thrombolytic...
Infinity Neuro receives CE-mark approval for aspiration catheter to treat stroke
Infinity Neuro announced today that its Inspira aspiration catheters have received CE-mark approval and are now commercially available in Europe.
This is the first offering from...
Interventions—not neuroimaging—found to be driving increased ischaemic stroke costs
A study by the Neiman Health Policy Institute (Reston, USA) has found that the costs of an ischaemic stroke episode increased by 4.9% from...
Imperative Care announces FDA clearance and initial cases with stroke-specific radial...
Imperative Care announced today that the US Food and Drug Administration (FDA) has finalised 510(k) clearance of its Zoom RDL radial access system—the company’s...
Study identifies “urgent need” to reduce burden of ischaemic stroke in...
A study published in Neurology has found that the burden of ischaemic stroke in young adults “continues to increase” across low-socio-demographic index (SDI) regions,...
iVascular launches new neurovascular portfolio with four CE-marked devices
Vascular device company iVascular has announced the expansion of its therapeutic areas with the launch of a new neurovascular pipeline, having gained CE-mark approval...
Process times and regional variation are main areas of concern for...
Technical and clinical outcomes associated with mechanical thrombectomy treatments in England are currently “acceptable”, but ‘drip-and-ship’ patients, process times and variation between units all...
US study bolsters recent evidence supporting tenecteplase in ischaemic stroke care
Tenecteplase, a newer-generation intravenous thrombolysis (IVT) drug, has outperformed the traditional treatment (alteplase) for ischaemic strokes in several key areas, demonstrating better health outcomes...
Imperative Care announces poster presentations on Zoom stroke solution at SNIS...
Imperative Care has announced that new data from studies evaluating the utility of the Zoom stroke solution for the treatment of ischaemic stroke will...
Alarming trends and alarmist myths: What is the link between COVID-19...
Over the course of the past two years, the accepted understanding of how COVID-19 spreads and functions has improved vastly, with preventative vaccines and...
ESOC 2022: New study links gut microbiota strains with more severe...
A new study has identified strains of gut microbiota that are associated with more severe strokes and worse post-stroke recovery, revealing that the gut...
Stroke in young people may be associated with increased likelihood of...
The risk of being diagnosed with a new cancer in the follow-up of patients with a first-ever stroke is particularly increased in patients younger...
Study findings encourage direct EVT approaches over bridging thrombolysis in select...
A retrospective study involving more than 200 patients has indicated that ‘bridging thrombolysis’ may not be associated with improved functional outcomes in stroke patients...
Michael Chen
Michael Chen—a neurointerventionist and professor of Neurology, Neurosurgery and Radiology at Rush University Medical Center in Chicago, USA—speaks to NeuroNews to provide insight on...
Study data indicate positive outcomes with “exciting new treatment option” in...
Data from a multicentre clinical study supporting the use of Anaconda Biomed’s Advanced Neurovascular Access (ANA) catheter system for treating ischaemic stroke have been...
Children with severe stroke may fare better if treatment includes mechanical...
Serious disability is six times more likely to be the result three months after stroke among children whose large-vessel stroke was not treated with...
Imperative launches Zoom POD aspiration tubing for use in stroke treatments
Imperative Care has announced the launch of its Zoom POD aspiration tubing—the company’s latest innovation in elevating stroke care.
This is the newest addition...
Worldwide stroke rates dip slightly over time, but overall numbers remain...
The worldwide incidence and mortality rates for stroke decreased slightly from 1990 to 2019, but the overall numbers remain high—especially in high- and middle-income...
First patient enrolled in pivotal EMAGINE trial of electromagnetic field therapy...
BrainQ has announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital (Washington, USA) in the pivotal, randomised, double-blind, multicentre EMAGINE...
Incidence of brain complications among hospitalised COVID-19 patients revealed in global...
The largest multi-institutional international study to date on brain complications associated with COVID-19 has found that approximately one in 100 patients hospitalised following SARS-CoV-2...
Hispanic stroke patients experience poorer post-thrombectomy outcomes than white counterparts
A study conducted by neurology researchers at University of Texas Southwestern (UTSW) Medical Center has found lower-quality functional outcomes for Hispanic ischaemic stroke patients...
Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions...
Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first ever trial...
Biomodex launches synthetic clot product for neurovascular training
Biomodex, a company specialising in biorealistic haptic simulators for physician training and rehearsals, has announced the launch of Thrombotech—a new, hydrogel-based synthetic clot product...
Imperative Care enrols first patient in trial evaluating Zoom 88 Large...
Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...
Study highlights temporal relationship between atrial fibrillation and stroke
Medtronic has announced the publication of a study demonstrating, through the use of a continuous rhythm monitoring device, that atrial fibrillation (AF) is directly...
Gender disparity in comprehensive stroke centre routing highlighted at SNIS
Women may be less likely than men to be sent to a comprehensive, or “Level 1”, stroke centre for emergent large vessel occlusion (ELVO)...
Sensome’s AI-powered stroke guidewire granted FDA Breakthrough Device designation
Sensome has announced its Clotild Smart Guidewire System—designed to improve the treatment of ischaemic stroke patients—has been granted a Breakthrough Device designation by the...
Higher incidence of severe stroke found in COVID-19 patients
Among people who have strokes and COVID-19, there is a higher incidence of severe stroke as well as a higher incidence of stroke in...
Perfuze announces CE mark and treats first patients with Millipede 088...
Neurovascular medical device company Perfuze has announced that the first five acute ischaemic stroke patients have been treated with its Millipede 088 clot aspiration...
Perflow Medical announces first clinical use of Stream17 Dynamic Neurothrombectomy Net
Perflow Medical has announced the first successful clinical use of its Stream17 Dynamic Neurothrombectomy Net—a lower profile device designed to effectively treat haemorrhagic and...
First US ischaemic stroke patients treated with Rapid Medical’s novel clot...
The first US patients have been treated with the FDA-cleared TIGERTRIEVER revascularisation device (Rapid Medical). TIGERTRIEVER is the first physician-adjustable stent retriever, according to...
Ischaemic stroke and TIA risk in COVID-19 patients lower than previously...
The elevated risk of ischaemic stroke and transient ischaemic attack TIA in hospitalised COVID-19 patients may be lower than previously reported—although it is still...
Study finds less than 2% of COVID-19 patients suffered ischaemic stroke
A study published in Stroke reviewing nearly 28,000 emergency department records across 54 healthcare facilities has shown that less than 2% of patients diagnosed with COVID-19 suffered...
Icometrix announces ischaemic stroke solution
In a press release, icometrix announced the addition of icobrain cva, a stroke solution, to the icobrain portfolio. According to the company, this announcement follows clearance from the US...
The post-stroke brain’s ability to recover and rewire itself peaks at...
A study published in Neurorehabilitation and Neural Repair finds that the capacity of the human brain to recover and rewire itself peaks around two...
Biomodex announce partnership to develop Evias Plus
Biomodex has announced its partnership with two of the top medical centres in France and a health system in the USA to develop Evias...
Seneca Biopharma announces phase II clinical study for treatment of ischaemic...
Seneca Biopharma has announced its preliminary top-line results of the placebo-controlled phase II stroke study that was conducted in Beijing, China.
According to a company...
New study supports Anaconda Biomed’s ANA catheter system for ischaemic stroke
New single-centre clinical study data published in the Journal of Neuroradiology claims to support the Anaconda Neurovascular Access (ANA) catheter system for the treatment...
Clot permeability linked to first-attempt success of aspiration thrombectomy
A multicentre study has reported that clot perviousness or permeability, the ability for contrast used during the initial imaging workup to seep through a...
Routine use of fluoxetine after acute stroke not recommended
The final results of EFFECTS (Efficacy of fluoxetine: A randomised controlled trial in stroke) have been presented by Erik Lundström (Uppsala University, Uppsala, Sweden)...
Large-vessel stroke: A feature of COVID-19 in the young
A case series of large-vessel stroke in patients younger than 50 years of age has been published in The New England Journal of Medicine....
Live from ISC: Fast treatment via mobile stroke unit found to...
Treating stroke patients in specialised ambulances speeds treatment and reduces patients’ disability, according to late-breaking science presented at the International Stroke Conference (ISC; 19–21...
US FDA clears Aidoc’s complete AI stroke package
Aidoc has announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging large vessel occlusion (LVO) in head...
Insera announces first two stroke patients treated with its cyclical aspiration...
Insera Therapeutics has announced that the first two ischaemic stroke patients have been treated with its flagship cyclic aspiration system, CLEAR. The company received...
Perfusion-weighted parameter is “outstanding” at detecting penumbral flow in acute stroke
The performance of the best perfusion-weighted measure—time-to-maximum—to detect the upper penumbral flow threshold in ischaemic stroke has been deemed “outstanding” by the study investigators....
Imperative Care announce US clearance of its ZOOM aspiration system
Imperative Care has announced US Food and Drug Administration (FDA) 510(k) clearance of the company’s ZOOM aspiration system—a family of products designed to facilitate...
Hospitals participating in Get With The Guidelines – Stroke offer higher...
A recent study reports data indicative of higher quality healthcare for hospitalised patients with ischaemic stroke at hospitals participating in the Get With The...
Canadian-led international study shows huge costs of delayed access to stroke...
It has been known for years that it is important to get stroke patient’s treatment as soon as possible to increase their chances of...
Phase 2 trial of novel treatment for ischaemic stroke initiated
Thrombolytic Science (TSI) has announced initiation of a phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of...
FDA approves septal occluder for PFO closure to prevent recurrent ischaemic...
The REDUCE clinical study demonstrated a 77% relative reduction in recurrent ischaemic stroke when patent foramen ovale (PFO) closure was combined with antiplatelet therapy,...
Sensome raises €4.7m to bring the world’s first connected stroke guidewire...
Sensome, formerly Instent, a company developing a micro-sensor technology for smart medical devices out of France’s Ecole polytechnique, Plaiseau, announced that it has completed...
TAVI Linked with bleeding in the brain and neurological impairment
Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarter developed new microbleeds in the brain after their procedure, according to...
